Global Prostate Cancer Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prostate Cancer Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prostate Cancer Drugs by Country/Region, 2017, 2022 & 2028

2.2 Prostate Cancer Drugs Segment by Type

2.2.1 Hormonal Therapy

2.2.2 Chemotherapy

2.2.3 Immunotherapy

2.2.4 Targeted Therapy

2.3 Prostate Cancer Drugs Sales by Type

2.3.1 Global Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prostate Cancer Drugs Sale Price by Type (2017-2022)

2.4 Prostate Cancer Drugs Segment by Application

2.4.1 Clinics

2.4.2 Hospitals

2.4.3 Others

2.5 Prostate Cancer Drugs Sales by Application

2.5.1 Global Prostate Cancer Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Prostate Cancer Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prostate Cancer Drugs Sale Price by Application (2017-2022)

3 Global Prostate Cancer Drugs by Company

3.1 Global Prostate Cancer Drugs Breakdown Data by Company

3.1.1 Global Prostate Cancer Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Prostate Cancer Drugs Sales Market Share by Company (2020-2022)

3.2 Global Prostate Cancer Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Prostate Cancer Drugs Revenue by Company (2020-2022)

3.2.2 Global Prostate Cancer Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Prostate Cancer Drugs Sale Price by Company

3.4 Key Manufacturers Prostate Cancer Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prostate Cancer Drugs Product Location Distribution

3.4.2 Players Prostate Cancer Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prostate Cancer Drugs by Geographic Region

4.1 World Historic Prostate Cancer Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Prostate Cancer Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prostate Cancer Drugs Annual Revenue by Geographic Region

4.2 World Historic Prostate Cancer Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Prostate Cancer Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prostate Cancer Drugs Annual Revenue by Country/Region

4.3 Americas Prostate Cancer Drugs Sales Growth

4.4 APAC Prostate Cancer Drugs Sales Growth

4.5 Europe Prostate Cancer Drugs Sales Growth

4.6 Middle East & Africa Prostate Cancer Drugs Sales Growth

5 Americas

5.1 Americas Prostate Cancer Drugs Sales by Country

5.1.1 Americas Prostate Cancer Drugs Sales by Country (2017-2022)

5.1.2 Americas Prostate Cancer Drugs Revenue by Country (2017-2022)

5.2 Americas Prostate Cancer Drugs Sales by Type

5.3 Americas Prostate Cancer Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Drugs Sales by Region

6.1.1 APAC Prostate Cancer Drugs Sales by Region (2017-2022)

6.1.2 APAC Prostate Cancer Drugs Revenue by Region (2017-2022)

6.2 APAC Prostate Cancer Drugs Sales by Type

6.3 APAC Prostate Cancer Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prostate Cancer Drugs by Country

7.1.1 Europe Prostate Cancer Drugs Sales by Country (2017-2022)

7.1.2 Europe Prostate Cancer Drugs Revenue by Country (2017-2022)

7.2 Europe Prostate Cancer Drugs Sales by Type

7.3 Europe Prostate Cancer Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Drugs by Country

8.1.1 Middle East & Africa Prostate Cancer Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prostate Cancer Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Prostate Cancer Drugs Sales by Type

8.3 Middle East & Africa Prostate Cancer Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prostate Cancer Drugs

10.3 Manufacturing Process Analysis of Prostate Cancer Drugs

10.4 Industry Chain Structure of Prostate Cancer Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prostate Cancer Drugs Distributors

11.3 Prostate Cancer Drugs Customer

12 World Forecast Review for Prostate Cancer Drugs by Geographic Region

12.1 Global Prostate Cancer Drugs Market Size Forecast by Region

12.1.1 Global Prostate Cancer Drugs Forecast by Region (2023-2028)

12.1.2 Global Prostate Cancer Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prostate Cancer Drugs Forecast by Type

12.7 Global Prostate Cancer Drugs Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Prostate Cancer Drugs Product Offered

13.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Astellas Pharma

13.2.1 Astellas Pharma Company Information

13.2.2 Astellas Pharma Prostate Cancer Drugs Product Offered

13.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Astellas Pharma Main Business Overview

13.2.5 Astellas Pharma Latest Developments

13.3 Astra Zeneca

13.3.1 Astra Zeneca Company Information

13.3.2 Astra Zeneca Prostate Cancer Drugs Product Offered

13.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Astra Zeneca Main Business Overview

13.3.5 Astra Zeneca Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Prostate Cancer Drugs Product Offered

13.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Prostate Cancer Drugs Product Offered

13.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

13.6 GlaxoSmithKline

13.6.1 GlaxoSmithKline Company Information

13.6.2 GlaxoSmithKline Prostate Cancer Drugs Product Offered

13.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Main Business Overview

13.6.5 GlaxoSmithKline Latest Developments

13.7 Merck Group

13.7.1 Merck Group Company Information

13.7.2 Merck Group Prostate Cancer Drugs Product Offered

13.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Group Main Business Overview

13.7.5 Merck Group Latest Developments

13.8 Novartis

13.8.1 Novartis Company Information

13.8.2 Novartis Prostate Cancer Drugs Product Offered

13.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novartis Main Business Overview

13.8.5 Novartis Latest Developments

13.9 Amgen

13.9.1 Amgen Company Information

13.9.2 Amgen Prostate Cancer Drugs Product Offered

13.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Amgen Main Business Overview

13.9.5 Amgen Latest Developments

13.10 Bayer HealthCare

13.10.1 Bayer HealthCare Company Information

13.10.2 Bayer HealthCare Prostate Cancer Drugs Product Offered

13.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bayer HealthCare Main Business Overview

13.10.5 Bayer HealthCare Latest Developments

13.11 Ferring Pharmaceutical

13.11.1 Ferring Pharmaceutical Company Information

13.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Product Offered

13.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ferring Pharmaceutical Main Business Overview

13.11.5 Ferring Pharmaceutical Latest Developments

13.12 Janssen Pharmaceuticals

13.12.1 Janssen Pharmaceuticals Company Information

13.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Product Offered

13.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Janssen Pharmaceuticals Main Business Overview

13.12.5 Janssen Pharmaceuticals Latest Developments

13.13 Endo Pharmaceuticals

13.13.1 Endo Pharmaceuticals Company Information

13.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Product Offered

13.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Endo Pharmaceuticals Main Business Overview

13.13.5 Endo Pharmaceuticals Latest Developments

13.14 BMS

13.14.1 BMS Company Information

13.14.2 BMS Prostate Cancer Drugs Product Offered

13.14.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 BMS Main Business Overview

13.14.5 BMS Latest Developments

13.15 Takeda Pharmaceuticals

13.15.1 Takeda Pharmaceuticals Company Information

13.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Product Offered

13.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Takeda Pharmaceuticals Main Business Overview

13.15.5 Takeda Pharmaceuticals Latest Developments

13.16 Northwest Biotherapeutics

13.16.1 Northwest Biotherapeutics Company Information

13.16.2 Northwest Biotherapeutics Prostate Cancer Drugs Product Offered

13.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Northwest Biotherapeutics Main Business Overview

13.16.5 Northwest Biotherapeutics Latest Developments

13.17 Teva Pharmaceutical

13.17.1 Teva Pharmaceutical Company Information

13.17.2 Teva Pharmaceutical Prostate Cancer Drugs Product Offered

13.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Teva Pharmaceutical Main Business Overview

13.17.5 Teva Pharmaceutical Latest Developments

13.18 Boehringer Ingelheim

13.18.1 Boehringer Ingelheim Company Information

13.18.2 Boehringer Ingelheim Prostate Cancer Drugs Product Offered

13.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Boehringer Ingelheim Main Business Overview

13.18.5 Boehringer Ingelheim Latest Developments

13.19 Foresee Pharmaceuticals

13.19.1 Foresee Pharmaceuticals Company Information

13.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Product Offered

13.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Foresee Pharmaceuticals Main Business Overview

13.19.5 Foresee Pharmaceuticals Latest Developments

13.20 Tokai Pharmaceuticals

13.20.1 Tokai Pharmaceuticals Company Information

13.20.2 Tokai Pharmaceuticals Prostate Cancer Drugs Product Offered

13.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Tokai Pharmaceuticals Main Business Overview

13.20.5 Tokai Pharmaceuticals Latest Developments

13.21 Spectrum Pharmaceuticals

13.21.1 Spectrum Pharmaceuticals Company Information

13.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offered

13.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Spectrum Pharmaceuticals Main Business Overview

13.21.5 Spectrum Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Prostate Cancer Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prostate Cancer Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hormonal Therapy

Table 4. Major Players of Chemotherapy

Table 5. Major Players of Immunotherapy

Table 6. Major Players of Targeted Therapy

Table 7. Global Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)

Table 8. Global Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Prostate Cancer Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Prostate Cancer Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Prostate Cancer Drugs Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)

Table 13. Global Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Prostate Cancer Drugs Revenue by Application (2017-2022)

Table 15. Global Prostate Cancer Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Prostate Cancer Drugs Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Prostate Cancer Drugs Sales by Company (2020-2022) & (K MT)

Table 18. Global Prostate Cancer Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Prostate Cancer Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Prostate Cancer Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Prostate Cancer Drugs Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Prostate Cancer Drugs Producing Area Distribution and Sales Area

Table 23. Players Prostate Cancer Drugs Products Offered

Table 24. Prostate Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Prostate Cancer Drugs Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Prostate Cancer Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Prostate Cancer Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Prostate Cancer Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Prostate Cancer Drugs Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Prostate Cancer Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Prostate Cancer Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Prostate Cancer Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)

Table 36. Americas Prostate Cancer Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Prostate Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Prostate Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)

Table 40. Americas Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)

Table 42. Americas Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Prostate Cancer Drugs Sales by Region (2017-2022) & (K MT)

Table 44. APAC Prostate Cancer Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Prostate Cancer Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Prostate Cancer Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)

Table 48. APAC Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)

Table 50. APAC Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)

Table 52. Europe Prostate Cancer Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Prostate Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Prostate Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)

Table 56. Europe Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)

Table 58. Europe Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Prostate Cancer Drugs Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prostate Cancer Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Prostate Cancer Drugs Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Prostate Cancer Drugs Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Prostate Cancer Drugs

Table 68. Key Market Challenges & Risks of Prostate Cancer Drugs

Table 69. Key Industry Trends of Prostate Cancer Drugs

Table 70. Prostate Cancer Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Prostate Cancer Drugs Distributors List

Table 73. Prostate Cancer Drugs Customer List

Table 74. Global Prostate Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Prostate Cancer Drugs Sales Market Forecast by Region

Table 76. Global Prostate Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Prostate Cancer Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Prostate Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Prostate Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Prostate Cancer Drugs Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Prostate Cancer Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Prostate Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Prostate Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Prostate Cancer Drugs Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Prostate Cancer Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Prostate Cancer Drugs Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Prostate Cancer Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Prostate Cancer Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Prostate Cancer Drugs Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Prostate Cancer Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Prostate Cancer Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Prostate Cancer Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. AbbVie Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. AbbVie Prostate Cancer Drugs Product Offered

Table 96. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. AbbVie Main Business

Table 98. AbbVie Latest Developments

Table 99. Astellas Pharma Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Astellas Pharma Prostate Cancer Drugs Product Offered

Table 101. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. Astellas Pharma Main Business

Table 103. Astellas Pharma Latest Developments

Table 104. Astra Zeneca Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Astra Zeneca Prostate Cancer Drugs Product Offered

Table 106. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Astra Zeneca Main Business

Table 108. Astra Zeneca Latest Developments

Table 109. Johnson & Johnson Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Johnson & Johnson Prostate Cancer Drugs Product Offered

Table 111. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Johnson & Johnson Main Business

Table 113. Johnson & Johnson Latest Developments

Table 114. Sanofi Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Sanofi Prostate Cancer Drugs Product Offered

Table 116. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. Sanofi Main Business

Table 118. Sanofi Latest Developments

Table 119. GlaxoSmithKline Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. GlaxoSmithKline Prostate Cancer Drugs Product Offered

Table 121. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. GlaxoSmithKline Main Business

Table 123. GlaxoSmithKline Latest Developments

Table 124. Merck Group Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck Group Prostate Cancer Drugs Product Offered

Table 126. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Merck Group Main Business

Table 128. Merck Group Latest Developments

Table 129. Novartis Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Novartis Prostate Cancer Drugs Product Offered

Table 131. Novartis Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Novartis Main Business

Table 133. Novartis Latest Developments

Table 134. Amgen Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Amgen Prostate Cancer Drugs Product Offered

Table 136. Amgen Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. Amgen Main Business

Table 138. Amgen Latest Developments

Table 139. Bayer HealthCare Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Bayer HealthCare Prostate Cancer Drugs Product Offered

Table 141. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 142. Bayer HealthCare Main Business

Table 143. Bayer HealthCare Latest Developments

Table 144. Ferring Pharmaceutical Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Ferring Pharmaceutical Prostate Cancer Drugs Product Offered

Table 146. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 147. Ferring Pharmaceutical Main Business

Table 148. Ferring Pharmaceutical Latest Developments

Table 149. Janssen Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Janssen Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 151. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 152. Janssen Pharmaceuticals Main Business

Table 153. Janssen Pharmaceuticals Latest Developments

Table 154. Endo Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Endo Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 156. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 157. Endo Pharmaceuticals Main Business

Table 158. Endo Pharmaceuticals Latest Developments

Table 159. BMS Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. BMS Prostate Cancer Drugs Product Offered

Table 161. BMS Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 162. BMS Main Business

Table 163. BMS Latest Developments

Table 164. Takeda Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Takeda Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 166. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 167. Takeda Pharmaceuticals Main Business

Table 168. Takeda Pharmaceuticals Latest Developments

Table 169. Northwest Biotherapeutics Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Northwest Biotherapeutics Prostate Cancer Drugs Product Offered

Table 171. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 172. Northwest Biotherapeutics Main Business

Table 173. Northwest Biotherapeutics Latest Developments

Table 174. Teva Pharmaceutical Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 175. Teva Pharmaceutical Prostate Cancer Drugs Product Offered

Table 176. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 177. Teva Pharmaceutical Main Business

Table 178. Teva Pharmaceutical Latest Developments

Table 179. Boehringer Ingelheim Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 180. Boehringer Ingelheim Prostate Cancer Drugs Product Offered

Table 181. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 182. Boehringer Ingelheim Main Business

Table 183. Boehringer Ingelheim Latest Developments

Table 184. Foresee Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 185. Foresee Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 186. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 187. Foresee Pharmaceuticals Main Business

Table 188. Foresee Pharmaceuticals Latest Developments

Table 189. Tokai Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 190. Tokai Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 191. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 192. Tokai Pharmaceuticals Main Business

Table 193. Tokai Pharmaceuticals Latest Developments

Table 194. Spectrum Pharmaceuticals Basic Information, Prostate Cancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 195. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offered

Table 196. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 197. Spectrum Pharmaceuticals Main Business

Table 198. Spectrum Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Prostate Cancer Drugs

Figure 2. Prostate Cancer Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prostate Cancer Drugs Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Prostate Cancer Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prostate Cancer Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hormonal Therapy

Figure 10. Product Picture of Chemotherapy

Figure 11. Product Picture of Immunotherapy

Figure 12. Product Picture of Targeted Therapy

Figure 13. Global Prostate Cancer Drugs Sales Market Share by Type in 2021

Figure 14. Global Prostate Cancer Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Prostate Cancer Drugs Consumed in Clinics

Figure 16. Global Prostate Cancer Drugs Market: Clinics (2017-2022) & (K MT)

Figure 17. Prostate Cancer Drugs Consumed in Hospitals

Figure 18. Global Prostate Cancer Drugs Market: Hospitals (2017-2022) & (K MT)

Figure 19. Prostate Cancer Drugs Consumed in Others

Figure 20. Global Prostate Cancer Drugs Market: Others (2017-2022) & (K MT)

Figure 21. Global Prostate Cancer Drugs Sales Market Share by Application (2017-2022)

Figure 22. Global Prostate Cancer Drugs Revenue Market Share by Application in 2021

Figure 23. Prostate Cancer Drugs Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Prostate Cancer Drugs Revenue Market Share by Company in 2021

Figure 25. Global Prostate Cancer Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Prostate Cancer Drugs Revenue Market Share by Geographic Region in 2021

Figure 27. Global Prostate Cancer Drugs Sales Market Share by Region (2017-2022)

Figure 28. Global Prostate Cancer Drugs Revenue Market Share by Country/Region in 2021

Figure 29. Americas Prostate Cancer Drugs Sales 2017-2022 (K MT)

Figure 30. Americas Prostate Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 31. APAC Prostate Cancer Drugs Sales 2017-2022 (K MT)

Figure 32. APAC Prostate Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Europe Prostate Cancer Drugs Sales 2017-2022 (K MT)

Figure 34. Europe Prostate Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Prostate Cancer Drugs Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Prostate Cancer Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Americas Prostate Cancer Drugs Sales Market Share by Country in 2021

Figure 38. Americas Prostate Cancer Drugs Revenue Market Share by Country in 2021

Figure 39. United States Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Prostate Cancer Drugs Sales Market Share by Region in 2021

Figure 44. APAC Prostate Cancer Drugs Revenue Market Share by Regions in 2021

Figure 45. China Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Prostate Cancer Drugs Sales Market Share by Country in 2021

Figure 52. Europe Prostate Cancer Drugs Revenue Market Share by Country in 2021

Figure 53. Germany Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Prostate Cancer Drugs Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Prostate Cancer Drugs Revenue Market Share by Country in 2021

Figure 60. Egypt Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Prostate Cancer Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Prostate Cancer Drugs in 2021

Figure 66. Manufacturing Process Analysis of Prostate Cancer Drugs

Figure 67. Industry Chain Structure of Prostate Cancer Drugs

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles